AQ Biotech
Non-invasive, antibody-free phage-biosensor diagnostics (cancer, infections, neurodegeneration) from accessible samples (saliva, urine) — strong patent portfolio. Series A in preparation; JVs in China (HK hub). Continues the technology of Aqsens Health (2017–2026); the old entity was wound up 29.5.2026 and the business now runs as AQ Biotech Oy (registered 2025).
The row
- Stage
- Pre-revenue — No sales yet
- Location
- Turku
- Founded
- 2025
- Business ID
- 3557225-2 · Finnish trade register
Links
Where this sits on the map
AQ Biotech is one of 33 companies in Therapeutics & Diagnostics. The others:
How this row was decided
Every row on this map is checked by hand against the trade register and the company's own material, and placed in the sector that best describes its business or its technology. Service firms and consultancies are left out, however advanced the technology they work with — the test is where the revenue comes from. Only funding figures the company or its investor has published are shown. The full rules are on the landscape ↗